The current PE ratio for Intuitive Surgical stock as of Jul 23, 2025 is 72.22. This is calculated based on the current EPS of $6.95 and the stock price of $501.95 per share. The P/E ratio has a decrease of 4.9% from the past four quarters average of 76.0.
The average historical PE ratio of Intuitive Surgical for the last ten years is 59.04. The current PE ratio of 72.22 is 22% above the historical average. Over the past ten years, ISRG's PE ratio was at its highest in the Dec 2020 quarter at 90.3, when the stock price was $272.7 and the EPS was $3.02. The lowest value was in the Sep 2015 quarter, when it reached 31.12 with a price of $51.03 and an EPS of $1.64.
Maximum annual increase: 107.66% in 2014
Maximum annual decrease: -47.3% in 2010
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 79.81 | 21.13% | $521.96 | $6.54 |
2023 | 65.89 | -7.63% | $337.36 | $5.12 |
2022 | 71.33 | -4.91% | $265.35 | $3.72 |
2021 | 75.01 | -16.93% | $359.3 | $4.79 |
2020 | 90.3 | 82.39% | $272.7 | $3.02 |
2019 | 49.51 | 2.65% | $197.05 | $3.98 |
2018 | 48.23 | -20.7% | $159.64 | $3.31 |
2017 | 60.82 | 84.69% | $121.65 | $2 |
2016 | 32.93 | -4.5% | $70.46 | $2.14 |
2015 | 34.48 | -26.07% | $60.68 | $1.76 |
2014 | 46.64 | 107.66% | $58.77 | $1.26 |
2013 | 22.46 | -24.55% | $42.68 | $1.9 |
2012 | 29.77 | -18.99% | $54.49 | $1.83 |
2011 | 36.75 | 38.57% | $51.45 | $1.4 |
2010 | 26.52 | -47.3% | $28.64 | $1.08 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 71.26 | -10.71% | $495.27 | $6.95 |
Dec 2024 | 79.81 | 2.83% | $521.96 | $6.54 |
Sep 2024 | 77.61 | 3.29% | $491.27 | $6.33 |
Jun 2024 | 75.14 | 6.19% | $444.85 | $5.92 |
Mar 2024 | 70.76 | 7.39% | $399.09 | $5.64 |
Dec 2023 | 65.89 | -2.62% | $337.36 | $5.12 |
Sep 2023 | 67.66 | -19.86% | $292.29 | $4.32 |
Jun 2023 | 84.43 | 22.61% | $341.94 | $4.05 |
Mar 2023 | 68.86 | -3.46% | $255.47 | $3.71 |
Dec 2022 | 71.33 | 46.89% | $265.35 | $3.72 |
Sep 2022 | 48.56 | -2.74% | $187.44 | $3.86 |
Jun 2022 | 49.93 | -23.7% | $200.71 | $4.02 |
Mar 2022 | 65.44 | -12.76% | $301.68 | $4.61 |
Dec 2021 | 75.01 | 7.74% | $359.3 | $4.79 |
Sep 2021 | 69.62 | 4.02% | $331.38 | $4.76 |
You can ether set your own Fair P/E multiple or use one of the automatically calculated Fair P/E multiples.
PE Ratio is an attempt to estimate a fair PE ratio of a stock based on its earnings and growth rate.
This formula is a modified version of the classic Graham-Dodd Formula (V= EPS x (8.5+2g)), originally developed by Benjamin Graham, to calculate the fair price of a stock based on its earnings and growth rate.
The formula we have created is an adaptation of this approach, designed to maintain a balance between simplicity and growth sensitivity.
It is calculated using the following formula:
IF g < 5: Fair PE = b
IF g >= 5: Fair PE = m × g
Here’s what each part of the formula means:
g: Growth is calculated as the average of the three-year average EPS growth rate and the one-year EPS growth rate (annually). This approach provides a balanced measure of growth by factoring in both the long-term growth trend and the most recent annual growth performance. If one of the growth metrics is not available, the remaining metric is used to determine growth. The fair P/E value is capped at 100 to prevent distortions caused by extreme EPS growth rates, such as those resulting from large percentage increases from a low base.
m: This is the long term historical median PEG (Price/Earnings to Growth) ratio of the overall market. It serves as a benchmark, adjusting the Fair PE based on typical market conditions.
b: Base PE (static value set to 8). If the company's growth rate is less than 5, the Fair PE is set at a conservative baseline of 8. This is because declining companies generally deserve a lower PE ratio.
Fixed: The Fair PE ratio for all data points is calculated using a single, constant average EPS growth rate, determined based on the most recent period. This means that the same growth rate is applied to all historical data points. Dynamic: The Fair PE ratio for each historical data point is calculated using the trailing average EPS growth rate specific to that point in time. This means that for each data point, the corresponding trailing EPS growth rate is used, ensuring that the Fair PE ratio reflects the growth conditions that were relevant at that specific point in history.
The current PE ratio of ISRG is greater than its 3, 5 and 10-year historical averages.
ISRG's PE ratio is lower than its peer stock BSX, but it is greater than JNJ's and SYK's. Intuitive Surgical is presently trading at a higher PE ratio (72.22) than its peer group average of 37.44.
Stock name | PE ratio | Market cap |
---|---|---|
CNMD CONMED Corp | 13.07 | $1.55B |
JNJ Johnson & Johnson | 18.66 | $406.87B |
MDT Medtronic plc | 25.35 | $117.89B |
HOLX Hologic Inc | 27.59 | $14.7B |
BDX Becton Dickinson & Co | 35.25 | $52.33B |
TFX Teleflex Inc | 35.96 | $5.18B |
IDXX Idexx Laboratories Inc | 49.51 | $43.48B |
SYK Stryker Corp | 53.46 | $153.22B |
ISRG Intuitive Surgical Inc | 72.22 | $179.91B |
BSX Boston Scientific Corp | 78.09 | $159.43B |
BAX Baxter International Inc | N/A | $14.66B |
ISRG stock has a price to earnings ratio of 72.22 as of Jul 23, 2025.
As an average over the last 3 years, ISRG stock has a PE ratio of 71.03.
As an average over the last 5 years, ISRG stock has a PE ratio of 71.12.
Over the last ten years, the quarterly PE ratio reached a historic high of 90.3 in the Dec 2020 quarter.
The current price to earnings ratio of ISRG is 22% higher than the 10-year historical average.
ISRG's PE ratio is high because the stock price is relatively expensive compared to the earnings generated by the company.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jul 23, 2025), Intuitive Surgical's stock price is $501.95. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $6.95. Therefore, Intuitive Surgical's P/E ratio for today is 72.22. PE RATIO(72.22) = STOCK PRICE($501.95) / TTM EPS($6.95)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.